Abstract | Iodine is a micronutrient that is essential for the production of thyroid hormones. The primary source of iodine is the diet via consumption of foods that have been fortified with iodine, including salt, dairy products and bread, or that are naturally abundant in the micronutrient, such as seafood. Recommended daily iodine intake is 150 μg in adults who are not pregnant or lactating. Ingestion of iodine or exposure above this threshold is generally well-tolerated. However, in certain susceptible individuals, including those with pre-existing thyroid disease, the elderly, fetuses and neonates, or patients with other risk factors, the risk of developing iodine-induced thyroid dysfunction might be increased. Hypothyroidism or hyperthyroidism as a result of supraphysiologic iodine exposure might be either subclinical or overt, and the source of the excess iodine might not be readily apparent.
Introduction
Iodine (atomic weight 126.9 g per atom) is a micro nutrient that is required for the synthesis of the thyroid hormones. It is a trace element in Earth's upper crust and is found primarily in or near coastal areas. For adults who are not lactating or pregnant, the US Institute of Medicine, and jointly by the WHO, United Nations Children's Fund (UNICEF) and the International Council for the Control of Iodine Deficiency Disorders (ICCIDD), recommend a daily iodine intake of 150 μg and state a tolerable upper level (the approximate threshold below which notable adverse effects are unlikely to occur in the healthy p opulation) of 1,100 μg per day in adults. 1, 2 However, iodine is present in concentrations up to several thousandfold higher than these amounts in medications, supplements and in the iodinated contrast agents used for radiologic studies (Box 1). In some sus ceptible indivi duals, the use of these iodinecontaining substances can result in thyroid dysfunction as a result of the high iodine load. In certain circumstances, iodine excess can result in adverse thyroidal effects after only a single exposure to an iodinerich substance.
Measures of iodine excess
Overall iodine levels cannot be reliably measured in indivi duals given the considerable daytoday variation in iodine intake. 3 Instead, median urinary iodine con centrations (UIC) have been widely used as a biomarker of population iodine intake, with levels >300 μg/l consid ered excessive in children and adults and levels >500 μg/l considered excessive in pregnant women. 2 In dried blood spots from children, the concentra tion of thyroglobulin correlates with iodine exposure and could be a novel marker for monitoring population iodine status in this age group. 4 In 2006, the international reference range of 4-40 μg/l for this assay was devel oped as a measure that indicates iodine sufficiency in children 5-14 years old. 4 This standard has since been adopted and recommended by the WHO, UNICEF and the ICCIDD as a method of assessing iodine nutrition in schoolaged children (≥6 years old). 2 One study demon strated that the mean concentration of thyroglobulin in dried blood spots was statistically significantly higher in healthy children aged 6-12 years in whom the median UIC was >300 μg/l than in those with lower UICs. 5 These findings suggest that levels of thyroglobulin in dried blood spots could be developed as a sensitive marker of iodine excess in this population. 5 
Thyroidal adaptation to excess iodine
The acute Wolff-Chaikoff effect was described in 1948 by Drs Jan Wolff and Israel Lyon Chaikoff at the University of California Berkeley, USA. 6 Wolff and Chaikoff observed a transient reduction (lasting ~24 h) in the synthesis of thyroid hormones in rats exposed to high amounts of iodide administered intraperitoneally. The mechanism for the acute Wolff-Chaikoff effect is not completely understood, but is thought to be at least partially explained by the generation of several inhibi tory substances (such as intrathyroidal iodolactones, iodoaldehydes and/or iodolipids) on thyroid peroxidase activity. 7 Reduced intrathyroidal deiodinase activity as a result of the increased iodine load might also contribute to decreased synthesis of thyroid hormones.
In most individuals, the decreased production of thyroid hormones is only transient and resumes after adaptation to the acute Wolff-Chaikoff effect. 7 In rats, this adaptation is associated with a marked decrease in expression of the sodium-iodide symporter (NIS) that is present on the basolateral membrane of thyroid follicu lar cells. 8 NIS is a 13transmembrane glycoprotein that mediates the active transport of iodine from the
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circulation into the thyroid. 9 The decrease in expression of the NIS occurs by 24 h after exposure to excess iodine and results in reduced intrathyroidal iodine concentra tions. In turn, the reduced iodine levels lead to a decrease in levels of the iodinated substances that inhibit synthesis of thyroid hormones, which results in the resumption of normal production of thyroid hormone (Figure 1 ).
In individuals with dysregulation of the thyroid folli cular cell, excess iodine exposure can induce thyroid dysfunction, which might be transient or permanent. 7 
Iodine-induced hypothyroidism
Vulnerable patients with specific risk factors might have an increased risk of failing to adapt to the acute Wolff-Chaikoff effect. 7 Susceptible patients include those with autoimmune thyroid disease; a previous history of surgery, 131 I or antithyroid drug therapy for Graves disease; subacute thyroiditis; postpartum thyroidi tis; type 2 amiodaroneinduced thyrotoxicosis (AIT); hemithyroidectomy; IFNα therapy; and concomitant use of potential goitrogens, such as lithium. Failure to escape from the acute Wolff-Chaikoff effect might also be more likely during fetal development, a period when the h ypothalamic-pituitary-thyroid axis is still i mmature, and during neonatal life.
The underlying mechanism of iodineinduced hypo thyroidism remains unclear, but could be attributable to failure to adapt to the acute Wolff-Chaikoff effect, prob ably because of a damaged thyroid as a result of previous Key points ■ Recommendations for iodine intake in adults who are not pregnant or lactating are 150 μg of iodine a day ■ Excess iodine exposure or ingestion can result in thyroid dysfunction in certain susceptible individuals, but is generally well-tolerated in most people ■ Iodine-induced thyroid dysfunction might be subclinical or overt and either transient or permanent ■ Sources of iodine excess include iodine supplementation to prevent iodine deficiency at a population level, the diet, vitamins and supplements, medications, contrast media and topical iodine ■ Supraphysiologic doses of iodine are appropriate in certain specific medical indications, including its use in the treatment of severe hyperthyroidism before thyroid surgery and as potassium iodide following a nuclear accident pathological insults. Exposure to high concentrations of iodine might also decrease the release of thyroid hormone, as reported in several small studies that show mild decreases in serum levels of thyroid hormone and increases in the serum level of TSH to the upper limit of the normal range. [10] [11] [12] Administration of iodine to patients with severe hyperthyroidism or thyroid storm is efficacious, as it results in an acute decrease in the release of thyroid hormones. 13 
Iodine-induced hyperthyroidism
In some susceptible patients, an excess iodine load pro vides a rich substrate for increased production of thyroid hormones. Iodineinduced hyperthyroidism (the JodBasedow phenomenon) was first described in the early 1800s, when thyrotoxicosis was observed to be more common among patients with endemic goiter treated with iodine supplementation than in individuals without goiter.
14 Iodineinduced hyperthyroidism might be trans ient or permanent, and risk factors include nontoxic or diffuse nodular goiter, latent Graves disease and long standing iodine deficiency. 7 In addition, iodineinduced hyperthyroidism in euthyroid patients with nodular goiter in iodinesufficient areas has also been reported when iodine supplementation is excessive. 15 
Sources of iodine excess
Iodine supplementation Globally, iodine supplementation has been the primary method over the past century to decrease iodine defi ciency, which is the leading cause of preventable mental retardation. 16 Iodine has been administrated as iodized oil orally and intramuscularly, introduced into the water supply, used in crop irrigation, incorporated into animal fodder and introduced into food through salt iodization, bread iodophors and other products. 17 Fortified micro nutrient biscuits have also been successfully used to raise the median UICs of schoolgirls (aged 10-15 years) in India. 18 Although iodine supplementation has decreased the number of people at risk of iodine deficiency and its associated sequelae, particularly in the past few decades, the use of iodine has also led to concerns of excessive iodine exposure in some individuals. A study published in 2012 reported that the median UIC (730 μg/l) of the populations of two Somali refugee camps in Kenya who were receiving iodine supplementation were in the range consistent with excessive iodine intake. 19 In a study of >200 Chinese adults, subclinical hypothyroid ism was more common in those supplemented with a 400 μg iodine tablet than in those given placebo. 20 These findings are similar to the results of other studies in Denmark 21 and New Zealand, 22 which also showed an increased prevalence of transient hyperthyroidism. The incidence of thyrotoxicosis was increased following periods of mandatory salt iodization, compared with when supplementation was not required, in both Spain 23 and Zimbabwe. 24 Another iodine supplementation pro gramme in Bangladesh has shown no increased risk of thyroid dysfunction. Iodine supplementation also affects other aspects of thyroid health. For example, high iodine intake seems to increase the prevalence of autoimmune thyroiditis in the Bio Breeding/Worcester rat model and in humans. 26, 27 The number of reported cases of thyroid cancer, particu larly papillary thyroid cancer, has also increased follow ing iodine supplementation in some studies, including a nearly 20year study in northeastern China 28 and a >50year study in Denmark. 29 
Diet
The diet is the main way of achieving adequate iodine nutrition. Dairy products (due to the use of iodophor cleaners for milk cans and teats), some breads (due to the use of iodate bread conditioners), seaweed and other seafood and iodized salt are the most common iodine containing foods. 30 In children from the USA aged 6-12 years, dairy intake is a particularly good source of adequate iodine, probably due to the abundance of dairy content in the diet of children in this age range. 31 Australia introduced iodization of bread in 2009, which resulted in a modest increase in the median UIC of a small group of pregnant women. 32 The amount of iodine that can be obtained from plantbased food is minimal and is dependent on the local environment (that is, iodine levels in the soil, groundwater used for irrigation, crop fertilizers and livestock feed). 33 The many varieties of seaweed are a unique potential source of excess ingestion of iodine. Seaweed is a popular food item in many parts of the world, particularly in Japan 34 and other Asian countries, where ingestion of seaweed soup is common in the everyday diet and is a fre quent practice during the postpartum period. 35 However, the iodine content of seaweed can vary widely. 36 Cases of kelpinduced thyrotoxicosis have been widely reported, including one woman who drank kelpcontaining tea for 4 weeks 37 and another patient who had a longstanding history of using kelpcontaining dietary supplements. 38 In other reports, chronic seaweed ingestion has also been reported to be associated with a modest increase in serum levels of TSH without overt thyroid dysfunction. 39, 40 The iodinerich content of the Japanese diet is unique and demonstrates how chronic exposure to excess iodine could result in several adaptive mechanisms. A 2013 paper reported a case of delayed onset congenital hypothyroid ism in an infant with a mutation in the gene that encodes dual oxidase (DUOX2), an enzyme known to be associ ated with transient congenital hypothyroidism, that was exacer bated by the infant's mother ingesting large amounts of seaweed during pregnancy. 41 Among Japanese school children (aged 6-12 years old), high UIC are associated with smaller thyroid glands than are found in children living in other iodinesufficient areas. 42 A comparison of individuals with negative thyroid antibody titres living in coastal regions versus noncoastal areas of Japan showed that people from areas in which iodinerich seaweed is abundant have an increased prevalence of hypothyroid ism (12.1% versus 2.3%). 43 Finally, a small study in Japan found that consumption of seaweed was positively associ ated with an increased risk of papillary thyroid cancers in postmenopausal women (HR 1.71, 95% CI 1.01-2.90). 44 The high iodine intake in Japan has probably reduced the adverse effects of the 2011 Fukushima reactor accident on thyroid function and radiationinduced thyroid cancer, as the uptake of radioactive iodine is inversely proportional to the ambient iodine intake.
Salt iodization is viewed as one of the safest and most effective methods of achieving iodine sufficiency across a population. 16 Iodine fortification of all foodgrade salt is mandated in ~120 countries, although the enforcement and degree of implementation of these efforts in indivi dual countries are unknown. 45 Although salt iodization is not obligatory in the USA and the FDA does not require that iodine content is listed on food labels, it is reassur ing that >90% of households in the USA have access to iodized salt. 16 Salt is not generally considered to be a source of excess iodine, although it is one of the most widely available iodinecontaining foods.
Vitamins and supplements
The iodine content of multivitamins is not uniform. 46 Supplements in the USA are not regulated by the FDA to the same rigorous standards as FDAapproved medica tions; therefore, their actual contents might not match the labelled content. In a US study published in 2009, iodine (as potassium iodide or kelp) was a labelled ingredient in only 51% of 223 prenatal nonprescription and prescrip tion multivitamins. 46 However, among the 25 brands containing iodine derived from kelp, measured values (33-610 μg per daily dose) were frequently discord ant with the labelled values (75-300 μg per daily dose), including 13 brands with a >50% discrepancy between the measured and labelled values. Thus, potassium iodide, and not kelp, should be used in vitamin preparations.
Several cases of congenital hypothyroidism caused by ingestion of excess maternal iodine tablets during preg nancy have been reported. 47 Similarly, hypothyroidism in neonates born to mothers who ingested excessive amounts of seaweed or seaweed soup during both pregnancy 48 and lactation have been reported. 49, 50 Given the risks of poten tial iodineinduced thyroid dysfunction, the American Thyroid Association recommends against ingestion of an iodine or kelp daily supplement containing >500 μg iodine for all individuals, except for certain medical indications. 51 Medications Amiodarone, an iodinerich medication used in the management of ventricular and supraventricular tachy arrhythmias, is probably the most important and common source of medicationinduced thyroid dysfunc tion. Amiodarone is 37% iodine by weight and has some structural resemblance to the thyroid hormones T 3 and T 4 . Thus, one 200 mg tablet of amiodarone contains 75 mg iodine, which is several hundredfold higher than the recom mended daily intake of 150 μg in adults. The drug has a long halflife of ~100 days, is very lipophilic and accumulates in various tissues, including adipose tissue, liver and the lungs. As a result of its high iodine content, use of amiodarone is associated with thyro toxicosis in 9.6% of patients with low ambient iodine intake, and hypothyroidism in 22.0% of patients with normal ambient iodine intake. 52 Overall, amiodaroneinduced hyper thyroidism is more common in iodinedeficient areas, whilst amiodaroneinduced hypothyroidism is more common in iodinesufficient areas.
Two types of AIT have been described: type 1 AIT is associated with increased synthesis of thyroid hor mones, whereas type 2 AIT is characterized by destructive thyroid itis. Both occur approximately three times more frequently in men than in women, which is in contrast to amiodaroneinduced hypothyroidism. 53 A comprehensive update on this topic was published in 2012. 54 Type 1 AIT is a form of the Jod-Basedow phenomenon, in which excess iodine exposure results in thyroid autonomy as a result of altered thyroid function regulation. Type 1 AIT is treated with thionamides, βblockers, and if available, per chlorate; corticosteroids could also be used if the initial treatment is not rapidly effective. By contrast, type 2 AIT is characterized by parts of the thyroid gland being destroyed, which results in thyroid hormones leaking into the circulation. Type 2 AIT is usually managed with cortico steroids; one trial has demonstrated that treatment with perchlorate did not improve the likelihood of restor ing euthyroidism. 55 In severe cases of AIT, thyroidectomy might be required, 56 with the use of iopanoic acid, if avail able, for the rapid control of hyperthyroidism before the surgery. 57 The discontinuation of amiodarone might be considered, if this strategy is tolerated by the patient and in collaborative discussion with the patient's cardiologist.
Some patients present with a mixed form of AIT, dis playing features of both type 1 AIT and type 2 AIT. 58 Differentiating between type 1 AIT and type 2 AIT can be difficult, but the use of radioiodine uptake and colour flow Doppler ultrasonography has been proposed. 58 Finally, the risk of AIT might be further increased in some patients who are concomitantly treated with war farin, due to a variety of mechanisms that can occur in patients who receive amiodarone that result in the p otentiation of the effects of warfarin. 59 Radiologic studies Use of iodinated contrast agents in diagnostic radiologic studies is a common source of excess iodine exposure in many patients. 60 A single dose of iodinated contrast can contain up to 13,500 μg of free iodine and 15-60 g of bound iodine (which is more than several thousand times above the recommended daily intake). 60 Following expo sure to an iodinated contrast agent, iodine stores in the body remain raised and provide a continuous pool that can potentially induce thyroid dysfunction. In euthyroid, healthy adults from the USA without previous thyroid or renal disease, UIC did not return to baseline in a study with a small number of participants until a median of 43 days following exposure to the contrast agent. 61 In another study of patients with athyreosis in Brazil, UICs did not normalize until 1 month after receiving a single intravenous contrast dose given for a CT scan. 62 Several case reports have demonstrated the effects of thyroid dysfunction arising after use of an iodinated contrast agent. For example, a 53yearold woman in the USA developed thyroid storm and cardio pulmonary arrest immediately after undergoing an iodinated radio logic study. 63 Two studies in Germany and the USA showed that a small proportion of patients who received either coronary angiography or an iodinated CT scan developed subclinical hypothyroidism ~1 week after the exam. 64, 65 A Turkish study of 101 patients who underwent coronary angiography found a small increased risk of subclinical hyperthyroidism at up to 8 weeks after the iodine exposure. 66 However, one small study showed that intravenous administration of an iodine contrast agent during pregnancy did not result in a notably increased incidence of fetal thyroid dysfunction. 67 Finally, we have reported the occurrence of iodineinduced hypothyroid ism in three neonates who received intravenous contrast agents to evaluate congenital cardiac defects. 68 One of the most rigorous studies that has examined the association between iodinated contrast use and thyroid dysfunction was a large case-control study that used medical records from two hospitals in Boston, USA, over a 20year period. 60 In this study, patients without preexisting hypothyroidism or hyperthyroid ism who received a single iodinated contrast dose had a 2-3fold increased risk of developing either incident hyperthyroidism (including overt hyperthyroidism) or overt hypothyroidism at a median of 9 months following exposure, compared with patients who did not receive the high iodine load.
Iodineinduced thyroid dysfunction is a potential consequence in patients with nodular goiters and/or elderly patients. 69, 70 Guidelines from the Contrast Media Safety Committee of the European Society of Urogenital Radiology advocate that highrisk patients are monitored for thyroid dysfunction following iodinated contrast use. 71 No guidelines are currently available for screen ing or followup of atrisk patients receiving iodinated contrast in the USA.
Topical iodine
The use of transdermal iodine and thyroid dysfunction associated with this practice is often seen in hospital ized neonates. 72 A study in Israel reported significantly higher serum levels of TSH in preterm neonates on whom topical iodinated antiseptic cleansers had been used than in preterm neonates on whom alcoholbased topical clean sers had been used (15.4 mIU/l versus 7.8 mIU/l, P <0.01). 73 Iodine is also frequently used as a topical anti septic in many surgical settings and for burn victims, whose ability to absorb topical iodine might be increased. 74 Iodineinduced thyrotoxicosis has been described in a paraplegic woman in the USA who had applied topical povidoneiodine prior to urinary selfcatheterization several times daily for many years. 7 Other sources of excess iodine exposure Other sources of potential excess iodine exposure include various expectorants, food preservatives, prescribed medi cations, parenteral nutrition preparations, mouthwashes 75 and vaginal douches. 11 Reversible increases in serum levels of TSH have been observed among US astronauts drinking iodinated water as purified drinking water 76 and individ uals ingesting water purified with iodinated tablets. 77 In the 1990s, due to the use of a faulty iodine based water filtration system, small increases in serum levels of TSH were detected in American Peace Corp workers in Niger; these changes resolved when the i odinated water source was no longer used. 78 
Indications for supraphysiologic iodine
Administration of supraphysiologic levels of iodine is medically appropriate in some very specific settings. A saturated solution of potassium iodide, of which the US generic formulation contains 1,000 mg potassium iodide per ml, can be used for the rapid treatment of hyper thyroidism, usually in patients with thyroid storm or in the preoperative period in patients with Graves disease, in conjunction with antithyroid drugs and other therapies. 13 In such patients, pharmacologic doses of iodine should be administered after a thionamide has been given to block excess synthesis of thyroid hormones. Finally, individuals in the vicinity of a nuclear power plant can be directed to take potassium iodide in the event of a nuclear accident to prevent uptake of radio active iodine into the thyroid, as was carried out in Poland following the Chernobyl nuclear accident. 79 
Conclusions
Iodine is required for the production of thyroid hor mones. Iodine is primarily taken in through the diet, with the recommended amount at 150 μg per day in adults who are not pregnant or lactating. Although excess iodine exposure generally does not result in any apparent clinical consequences, thyroid dysfunction can occur in vulner able patients with specific risk factors, including those with preexisting thyroid disease, the elderly, fetuses and neonates. As iodineinduced hypothyroidism or hyper thyroidism might be either subclinical or overt, excess iodine exposure should be suspected if the a etiology of thyroid dysfunction is not discernible.
